CMS to Cover Colorguard Test

The Centers for Medicare & Medicaid Services (CMS) announced October 9 in a decision memo that it will cover the Colorguard™ test — a multitarget stool DNA test — as a colorectal cancer screening test. Conditions Apply The Colorguard™ test will be covered under Medicare Part B once every three years  for asymptomatic, average risk beneficiaries, aged 50 to 85 […]